Epidemiology of ovarian cancer: a review
暂无分享,去创建一个
[1] V. Beral. Ovarian cancer and hormone replacement therapy in the Million Women Study , 2007, The Lancet.
[2] E. Vogtmann,et al. Age at menarche and risk of ovarian cancer: A meta‐analysis of epidemiological studies , 2013, International journal of cancer.
[3] B. Henderson,et al. Reproductive, genetic, and dietary risk factors for ovarian cancer. , 1988, American journal of epidemiology.
[4] Dana-Adriana Botesteanu. Mathematical Models for Ovarian Cancer , 2017 .
[5] B. Kupelnick,et al. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies. , 2003, Anticancer research.
[6] C. Bain,et al. Alcohol, wine, and risk of epithelial ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[7] J. Stanford,et al. Ovarian cancer incidence among Asian migrants to the United States and their descendants. , 1994, Journal of the National Cancer Institute.
[8] S. Grénman,et al. Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland , 2014, Obstetrics and gynecology.
[9] D. Thomas,et al. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[10] O. Sheils,et al. Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion , 2015, BMC Cancer.
[11] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[12] K. Arga,et al. Molecular signatures of ovarian diseases: Insights from network medicine perspective , 2016, Systems biology in reproductive medicine.
[13] S. Kjaer,et al. Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors , 2013, Cancer Causes & Control.
[14] B. Modan,et al. Cancer incidence in a cohort of infertile women. , 1987, American journal of epidemiology.
[15] J. Buring,et al. Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[16] V. Siskind,et al. Reproductive and other factors and risk of epithelial ovarian cancer: An australian case‐control study , 1995, International journal of cancer.
[17] Charles E. Matthews,et al. Physical Activity in Different Periods of Life, Sedentary Behavior, and the Risk of Ovarian Cancer in the NIH-AARP Diet and Health Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[18] D. Thomas,et al. High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1992, European journal of cancer.
[19] L. Kolonel,et al. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. , 2005, American journal of epidemiology.
[20] Andy H. Lee,et al. Sedentary behaviours and epithelial ovarian cancer risk , 2004, Cancer Causes & Control.
[21] R. Ness,et al. Alcohol Consumption and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer , 2003, Obstetrics and gynecology.
[22] A. Russo,et al. Hereditary ovarian cancer. , 2009, Critical reviews in oncology/hematology.
[23] D. Machin. Trends in Cancer Incidence and Mortality , 1995, British Journal of Cancer.
[24] P. Hartge,et al. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. , 2006, Journal of the National Cancer Institute.
[25] Kathleen M. Fairfield,et al. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. , 2007, American journal of epidemiology.
[26] L. Jones,et al. Recreational physical activity and ovarian cancer risk and survival. , 2011, Annals of epidemiology.
[27] N. Weiss,et al. Incomplete pregnancies and risk of ovarian cancer (Washington, United States) , 1996, Cancer Causes & Control.
[28] M. Cotterchio,et al. Surgical procedures associated with risk of ovarian cancer. , 1997, International journal of epidemiology.
[29] J. Monaghan,et al. The epidemiology of ovarian cancer , 2001, International Journal of Gynecologic Cancer.
[30] R. Gordon,et al. Asbestos exposure and ovarian fiber burden. , 1996, American journal of industrial medicine.
[31] L. Aaltonen,et al. Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome , 1995, International journal of cancer.
[32] P. Nasca,et al. An epidemiologic case-control study of ovarian cancer and reproductive factors. , 1984, American journal of epidemiology.
[33] S. Coughlin,et al. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. , 2000, Journal of clinical epidemiology.
[34] Sebastian M. Armasu,et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer , 2013, Nature Communications.
[35] R. Goldbohm,et al. Physical Activity and Risk of Ovarian Cancer: Results from the Netherlands Cohort Study (The Netherlands) , 2005, Cancer Causes & Control.
[36] V. Beral,et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls , 2008, The Lancet.
[37] I. Shih,et al. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high‐grade serous carcinoma—evidence supporting the clonal relationship of the two lesions , 2012, The Journal of pathology.
[38] M. Thun,et al. Tubal ligation and fatal ovarian cancer in a large prospective cohort study. , 1997, American journal of epidemiology.
[39] F. Bray,et al. Ovarian cancer in Europe: Cross‐sectional trends in incidence and mortality in 28 countries, 1953–2000 , 2005, International journal of cancer.
[40] A. Godwin,et al. Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management , 2009, Molecular oncology.
[41] L. Sobin,et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. , 2003, American journal of epidemiology.
[42] P. A. van den Brandt,et al. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] M. King,et al. Mutation analysis of the BRCA1 gene in ovarian cancers. , 1995, Cancer research.
[44] A. Uitterlinden,et al. Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.
[45] D. Easton,et al. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer , 2000, International journal of cancer.
[46] V. Beral,et al. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. , 2015, Lancet.
[47] C. Carlson,et al. Genetic Variation and Reproductive Timing: African American Women from the Population Architecture Using Genomics and Epidemiology (PAGE) Study , 2013, PloS one.
[48] Ken R. Smith,et al. Ovarian cancer mortality among immigrants in Australia and Canada. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[49] M. Gwinn,et al. Alcohol consumption and ovarian cancer risk. , 1986, American journal of epidemiology.
[50] P. Hartge,et al. A case-control study of epithelial ovarian cancer. , 1989, American journal of obstetrics and gynecology.
[51] V. Beral,et al. Risk factors for ovarian cancer: a case-control study. , 1989, British Journal of Cancer.
[52] V. Beral,et al. Pooled analysis of 3 european case‐control studies of ovarian cancer: II. Age at menarche and at menopause , 1991, International journal of cancer.
[53] M. Pike,et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. , 2013, Endocrine-related cancer.
[54] D. Thomas,et al. Lactation and the risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1993, International journal of epidemiology.
[55] A. Folsom,et al. Estrogen Replacement Therapy and Ovarian Cancer , 2004, Epidemiology.
[56] M. Cotterchio,et al. Association between frequency and intensity of recreational physical activity and epithelial ovarian cancer risk by age period , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[57] Bin Wang,et al. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. , 2008, Gynecologic oncology.
[58] J. Cerhan,et al. Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women , 2004, Cancer Causes & Control.
[59] Kconfab Investigators,et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer , 2015 .
[60] K. Robien,et al. Tea Consumption and Epithelial Ovarian Cancer Risk: A Systematic Review of Observational Studies , 2011, Nutrition and cancer.
[61] X. Shu,et al. Population-based case-control study of ovarian cancer in Shanghai. , 1989, Cancer research.
[62] Gordon B Mills,et al. Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon , 2005, Clinical Cancer Research.
[63] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[64] V. Cogliano. International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.
[65] H. Grönberg,et al. Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors. , 2011, Gynecologic oncology.
[66] H. Risch,et al. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. , 1994, American journal of epidemiology.
[67] S. Larsson,et al. Wine consumption and epithelial ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[68] F. Camacho,et al. Analgesic medication use and risk of epithelial ovarian cancer in African American women , 2016, British Journal of Cancer.
[69] D. English,et al. Physical activity, body size and composition, and risk of ovarian cancer , 2010, Cancer Causes & Control.
[70] M. Newhouse,et al. A case control study of carcinoma of the ovary. , 1977, British journal of preventive & social medicine.
[71] C. la Vecchia,et al. Risk factors for epithelial ovarian cancer in Italy. , 1982, American journal of epidemiology.
[72] Susan Halabi,et al. Cyclin E Overexpression in Epithelial Ovarian Cancer Characterizes an Etiologic Subgroup , 2008, Cancer Epidemiology Biomarkers & Prevention.
[73] H. Howe,et al. Pathology and classification of ovarian tumors , 2003, Cancer.
[74] X. Shu,et al. Occupational physical activity and the incidence of cancer of the breast, corpus uteri, and ovary in shanghai , 1993, Cancer.
[75] Lara E Sucheston-Campbell,et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[76] M. Sowers,et al. Effects of smoking on the development of female reproductive cancers. , 1984, Journal of the National Cancer Institute.
[77] S. Pan,et al. Physical activity and the risk of ovarian cancer: A case‐control study in Canada , 2005, International journal of cancer.
[78] S. Hankinson,et al. Perineal use of talc and risk of ovarian cancer , 2008, Journal of Epidemiology & Community Health.
[79] Yan-Hong Huang,et al. Association between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective observational studies , 2015, BMC Public Health.
[80] H. Xing,et al. Aspirin inhibits growth of ovarian cancer by upregulating caspase-3 and downregulating bcl-2 , 2016, Oncology letters.
[81] L. Brinton,et al. Prospective study of physical activity and the risk of ovarian cancer , 2009, Cancer Causes & Control.
[82] M. Goodman,et al. Alcohol Consumption and the Risk of Borderline and Invasive Ovarian Cancer , 2003, Obstetrics and gynecology.
[83] V. Beral,et al. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies , 2015, The Lancet.
[84] A. Whittemore,et al. Histologic types of epithelial ovarian cancer: have they different risk factors? , 2005, Gynecologic oncology.
[85] T. Oppé,et al. Vitamin D deficiency. , 1979, British medical journal.
[86] M. Pike,et al. Oral contraceptives and ovarian cancer. , 1983, The New England journal of medicine.
[87] C. la Vecchia,et al. Physical activity and risk of ovarian cancer: An Italian case‐control study , 2001, International journal of cancer.
[88] P. Hartge,et al. Menopause and ovarian cancer. , 1988, American journal of epidemiology.
[89] Alcohol , 1984, Peptides.
[90] W. McCluggage,et al. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. , 2011, Pathology.
[91] C. la Vecchia,et al. Incomplete pregnancies and ovarian cancer risk. , 1992, Gynecologic oncology.
[92] M. Gultekin,et al. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers , 2004, Acta obstetricia et gynecologica Scandinavica.
[93] C. Jackson,et al. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents , 2014, International journal of epidemiology.
[94] C. la Vecchia,et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. , 1994, Human reproduction.
[95] A. Whittemore,et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. , 2016, American journal of epidemiology.
[96] D. Cramer,et al. Evidence of Differential Effects of Vitamin D Receptor Variants on Epithelial Ovarian Cancer Risk by Predicted Vitamin D Status , 2014, Front. Oncol..
[97] K. Kerlikowske,et al. HORMONE REPLACEMENT THERAPY AND THE RISK OF EPITHELIAL OVARIAN CARCINOMA: A META‐ANALYSIS , 1998, Obstetrics and gynecology.
[98] H. Brenner,et al. Meta-analysis: Circulating vitamin D and ovarian cancer risk. , 2011, Gynecologic oncology.
[99] M. Pike,et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies , 2012, The Lancet. Oncology.
[100] M. Pike,et al. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin , 2009, Cancer.
[101] Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review , 1996, Cancer.
[102] Yashuang Zhao,et al. Breastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[103] L. Schouten,et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls , 2009 .
[104] W. Willett,et al. Tubal Ligation, Hysterectomy, and Risk of Ovarian Cancer: A Prospective Study , 1993 .
[105] E. Weiderpass,et al. Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. , 2011, International journal of oncology.
[106] M. Janicek,et al. Ovarian carcinoma: A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention , 1994 .
[107] A. Whittemore,et al. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. , 1993, Journal of the National Cancer Institute.
[108] C. Bain,et al. Tea consumption and risk of ovarian cancer , 2010, Cancer Causes & Control.
[109] D. Trump,et al. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.
[110] J. Kelsey,et al. An epidemiologic study of epithelial carcinoma of the ovary. , 1981, American journal of epidemiology.
[111] K. Moysich,et al. Consumption of black tea or coffee and risk of ovarian cancer , 2006, International Journal of Gynecologic Cancer.
[112] C. la Vecchia,et al. Age at first birth and the risk of epithelial ovarian cancer. , 1984, Journal of the National Cancer Institute.
[113] W. Su,et al. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. , 2011, The Lancet. Oncology.
[114] J. Doherty,et al. Breast-feeding and risk of epithelial ovarian cancer , 2012, Cancer Causes & Control.
[115] C. la Vecchia,et al. Global trends and predictions in ovarian cancer mortality. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[116] D. Apter,et al. Life‐long physical activity and cancer risk among Finnish female teachers , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[117] Hui Xu,et al. The VDR gene FokI polymorphism and ovarian cancer risk , 2013, Tumor Biology.
[118] R. Crawford,et al. Endometriosis and Ovarian Cancer: A Systematic Review , 2011, ISRN obstetrics and gynecology.
[119] J. Stanford,et al. Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1989, International journal of epidemiology.
[120] I. Gram,et al. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition , 2011, British Journal of Cancer.
[121] C. la Vecchia. Oral contraceptives and ovarian cancer: an update, 1998–2004 , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[122] Y. Lee,et al. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis , 2013, Immunological investigations.
[123] V. Beral,et al. Pooled analysis of 3 european case‐control studies of epithelial ovarian cancer: III. Oral contraceptive use , 1991, International journal of cancer.
[124] J. Muscat,et al. Perineal talc use and ovarian cancer: a critical review , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[125] Yurii B. Shvetsov,et al. Genome-wide significant risk associations for mucinous ovarian carcinoma , 2015, Nature Genetics.
[126] Brooke L. Fridley,et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.
[127] D. Easton,et al. Contribution of BRCA1 mutations to ovarian cancer. , 1997, The New England journal of medicine.
[128] S. Kjaer,et al. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. , 2016, Gynecologic oncology.
[129] Yurii B. Shvetsov,et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. , 2016, International journal of epidemiology.
[130] Cuntong Wang. Trends in contraceptive use and determinants of choice in China: 1980-2010. , 2012, Contraception.
[131] Shui Wang,et al. Meta‐analysis on the association between non‐steroidal anti‐inflammatory drug use and ovarian cancer , 2013, British journal of clinical pharmacology.
[132] Helena Carreira,et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.
[133] A. Ziogas,et al. Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. , 2000, European journal of cancer.
[134] R. Mathur,et al. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. , 1985, Maturitas.
[135] H. Risch. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. , 1999, Journal of the National Cancer Institute.
[136] Kurt Straif,et al. Carcinogenicity of carbon black, titanium dioxide, and talc. , 2006, The Lancet Oncology.
[137] C. la Vecchia. Epidemiology of ovarian cancer: a summary review , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[138] L. Petersen,et al. Physical activity in leisure-time and risk of cancer: 14-year follow-up of 28,000 Danish men and women , 2005, Scandinavian journal of public health.
[139] P. Dickman,et al. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women , 2004, European Journal of Epidemiology.
[140] M. Goodman,et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. , 2002, American journal of epidemiology.
[141] P. Wingo,et al. The reduction in risk of ovarian cancer associated with oral-contraceptive use. , 1987, The New England journal of medicine.
[142] A. Whittemore,et al. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. , 1988, American journal of epidemiology.
[143] T. Sellers,et al. Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer , 2012, British Journal of Cancer.
[144] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[145] Wei Lu,et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.
[146] A. Wolk,et al. Red and processed meat consumption and risk of ovarian cancer: a dose-response meta-analysis of prospective studies , 2011, British Journal of Cancer.
[147] A. Good. Estrogens and Progestogens in Clinical Practice , 1999 .
[148] S. Shapiro,et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. , 1994, American journal of epidemiology.
[149] Wanqing Chen,et al. Ovary cancer incidence and mortality in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[150] A. Berchuck,et al. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States) , 2002, Cancer Causes & Control.
[151] D. Whiteman,et al. Does smoking increase risk of ovarian cancer? A systematic review. , 2006, Gynecologic Oncology.
[152] R. Goldbohm,et al. Consumption of dietary fat and meat and risk of ovarian cancer in the Netherlands Cohort Study. , 2011, The American journal of clinical nutrition.
[153] S. Nilsson,et al. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies , 2004, Acta obstetricia et gynecologica Scandinavica.
[154] Jacques Ferlay,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .
[155] B. Rosen,et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. , 2001, American journal of human genetics.
[156] R. Ness,et al. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. , 2011, Annals of epidemiology.
[157] H. Martha,et al. Endometriosis , 2015 .
[158] C. la Vecchia,et al. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. , 2005, Gynecologic oncology.
[159] Xiaocheng Wu,et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations , 2006, Cancer.
[160] C. la Vecchia,et al. Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. , 2012, Alcohol and alcoholism.
[161] R. Berkowitz,et al. Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.
[162] P. Ridker,et al. Genome-wide association studies identify novel loci associated with age at menarche and age at natural menopause , 2009, Nature Genetics.
[163] J. Klijn,et al. Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers , 2004, Clinical Cancer Research.
[164] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[165] S. Nilsson,et al. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence , 1998, Clinical endocrinology.
[166] P. Hartge,et al. Risk factors in ovarian cancer. , 1988, European journal of gynaecological oncology.
[167] I. Shih,et al. Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases , 2009, The American journal of surgical pathology.
[168] J. Prat. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features , 2012, Virchows Archiv.
[169] H. Langseth,et al. Asbestos fibers in ovarian tissue from Norwegian pulp and paper workers , 2006, International Journal of Gynecologic Cancer.
[170] A. Whittemore,et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. , 2016, International journal of epidemiology.
[171] D. Cramer,et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. , 1983, Journal of the National Cancer Institute.
[172] C. Bain,et al. Meat, fish, and ovarian cancer risk: Results from 2 Australian case-control studies, a systematic review, and meta-analysis. , 2010, The American journal of clinical nutrition.
[173] Å. Borg,et al. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. , 2004, European journal of cancer.
[174] K. Hemminki,et al. Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer? , 2011, European journal of cancer.
[175] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[176] D. Cramer,et al. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.
[177] V. Siskind,et al. Incomplete pregnancy and risk of ovarian cancer: results from two Australian case–control studies and systematic review , 2009, Cancer Causes & Control.
[178] Setsuko K Chambers,et al. Tubal origin of ovarian low-grade serous carcinoma. , 2013, American journal of clinical and experimental obstetrics and gynecology.
[179] P. V. van Diest,et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.
[180] J. Onwude. Hormone therapy and ovarian cancer , 2015, The Lancet.
[181] L. Zelek,et al. Prospective association between alcohol intake and hormone-dependent cancer risk: modulation by dietary fiber intake. , 2015, The American journal of clinical nutrition.
[182] B. Rosner,et al. Risk factors for epithelial ovarian cancer by histologic subtype. , 2010, American journal of epidemiology.
[183] Robert C. Lee,et al. A systematic literature review of vitamin D and ovarian cancer. , 2010, American journal of obstetrics and gynecology.
[184] M. Morgan,et al. Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives , 2001 .
[185] C. Friedenreich,et al. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition , 2009, International journal of cancer.
[186] P. Vercellini,et al. Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer. , 2007, Fertility and sterility.
[187] T. Oury,et al. Experimental Models of Asbestos-Related Diseases , 2014 .
[188] Esther Cheng,et al. Robbins Basic Pathology. , 2017, American journal of clinical pathology.
[189] A. Berchuck,et al. Ovarian cancer risk factors in African-American and white women. , 2009, American journal of epidemiology.
[190] M. Rossing,et al. Analgesic drug use and risk of epithelial ovarian cancer. , 2008, American journal of epidemiology.
[191] W. O'Fallon,et al. Ovarian cancer. Incidence and case‐control study , 1979, Cancer.
[192] C. la Vecchia,et al. Risk factors for ovarian cancer histotypes. , 2007, European journal of cancer.
[193] Ming Wu,et al. Increase of Incidence and Mortality of Ovarian Cancer during 2003–2012 in Jiangsu Province, China , 2016, Front. Public Health.
[194] A. Sood,et al. Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer , 2016, Molecular Cancer Therapeutics.
[195] M. Thun,et al. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[196] Andy H. Lee,et al. Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies , 2012, The Lancet. Oncology.
[197] F. Clavel-Chapelon,et al. Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition , 2006, Cancer Causes & Control.
[198] B. Rosner,et al. Surrogates of Long-Term Vitamin D Exposure and Ovarian Cancer Risk in Two Prospective Cohort Studies , 2013, Cancers.
[199] D. Trichopoulos,et al. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer , 1993, International journal of cancer.
[200] M. Thun,et al. Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen , 2010, International journal of cancer.
[201] L. Aaltonen,et al. Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.
[202] Hongbing Shen,et al. Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women , 2022 .
[203] A. Berchuck,et al. Analgesic Drug Use and Risk of Ovarian Cancer , 2006, Epidemiology.
[204] A. Folsom,et al. Anthropometric variables, physical activity, and incidence of ovarian cancer , 2004, Cancer.
[205] C. Friedenreich,et al. Physical Activity and Ovarian Cancer Risk: the European Prospective Investigation into Cancer and Nutrition , 2009, Cancer Epidemiology Biomarkers & Prevention.
[206] N. Le,et al. Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case-control study. , 2016, Gynecologic oncology.
[207] B. Rosner,et al. American Journal of Epidemiology Original Contribution Use of Nonsteroidal Antiinflammatory Agents and Incidence of Ovarian Cancer in 2 Large Prospective Cohorts , 2022 .
[208] K. Yoo,et al. Menstrual factors and cancer risk among Korean women. , 2011, International journal of epidemiology.
[209] Donghui Li. Metformin as an antitumor agent in cancer prevention and treatment , 2011, Journal of diabetes.
[210] J. Ferlay,et al. Worldwide burden of gynaecological cancer: the size of the problem. , 2006, Best practice & research. Clinical obstetrics & gynaecology.
[211] L. Titus,et al. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. , 2013, Human reproduction.
[212] J. Chang-Claude,et al. Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[213] A. Kriska,et al. Physical Activity and Reduced Risk of Ovarian Cancer , 2000, Obstetrics and gynecology.
[214] X. Shu,et al. Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study , 2015, International Journal of Cancer.
[215] A. Folsom,et al. Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[216] V. Siskind,et al. Breastfeeding and risk of epithelial ovarian cancer , 2009, Cancer Causes & Control.
[217] H. Risch,et al. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[218] C. Bain,et al. Recreational Physical Activity and Epithelial Ovarian Cancer: A Case-Control Study, Systematic Review, and Meta-analysis , 2007, Cancer Epidemiology Biomarkers & Prevention.
[219] M. Thun,et al. Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. , 2006, American journal of epidemiology.
[220] Yurii B. Shvetsov,et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer , 2015, Nature Genetics.
[221] R. Hayes,et al. Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey , 1993, Cancer Causes & Control.
[222] S. Lowry,et al. Incessant ovulation and ovarian cancer , 1991, The Lancet.
[223] D. Cramer,et al. Cigarette Smoking and Epithelial Ovarian Cancer by Histologic Type , 2000, Obstetrics and gynecology.
[224] M. Quinn,et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer , 1997, International journal of cancer.
[225] M. Thun,et al. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. , 2001, JAMA.
[226] C. la Vecchia,et al. Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis. , 2012, Gynecologic oncology.
[227] Andy H. Lee,et al. Physical activity and epithelial ovarian cancer risk: A case‐control study in China , 2003, International journal of cancer.
[228] S. Shapiro,et al. Noncontraceptive estrogen use and epithelial ovarian cancer. , 1989, American journal of epidemiology.
[229] R. Hayes,et al. Circulating 25-Hydroxyvitamin D and Risk of Epithelial Ovarian Cancer , 2010, American journal of epidemiology.
[230] F. Camacho,et al. Recreational physical activity and ovarian cancer risk in African American women , 2016, Cancer medicine.
[231] A. Jensen,et al. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case–control study , 2012, Acta obstetricia et gynecologica Scandinavica.
[232] V. Beral,et al. Pooled analysis of 3 european case‐control studies: I. Reproductive factors and risk of epithelial ovarian cancer , 1991, International journal of cancer.
[233] W. Aronow,et al. Prevalence and Causes of Persistent Use of Hormone Replacement Therapy Among Postmenopausal Women: A Follow-Up Study , 2006, American journal of therapeutics.
[234] R. Goldbohm,et al. Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study , 2004, Cancer Causes & Control.
[235] J. Schildkraut,et al. Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome , 1996, Obstetrics and gynecology.
[236] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[237] S. Kjaer,et al. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. , 1997, Fertility and sterility.
[238] W. Chung,et al. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.
[239] Lara E Sucheston-Campbell,et al. Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[240] M. Pike,et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. , 2014, Journal of the National Cancer Institute.
[241] R. Hayes,et al. Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2010, American journal of epidemiology.
[242] S. Kjær,et al. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case–control study , 2015, Acta obstetricia et gynecologica Scandinavica.
[243] E. Funkhouser,et al. Reproductive factors and ovarian cancer risk in African-American women. , 2016, Annals of epidemiology.
[244] Russell Vang,et al. Fallopian tube precursors of ovarian low‐ and high‐grade serous neoplasms , 2013, Histopathology.
[245] P. Hartge,et al. Risk factors for epithelial ovarian cancer in Beijing, China. , 1992, International journal of epidemiology.
[246] T. Rebbeck,et al. Prophylactic oophorectomy in women at increased cancer risk , 2007, Current opinion in obstetrics & gynecology.
[247] T. VanderWeele,et al. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine , 2016, Epidemiology.
[248] Andy H. Lee,et al. Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies , 2012, PLoS medicine.
[249] W. Willett,et al. A prospective study of reproductive factors and risk of epithelial ovarian cancer , 1995, Cancer.
[250] L. Titus,et al. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case–Control Study , 2013, International journal of cancer.
[251] M. King,et al. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary , 2000, International journal of cancer.
[252] Enrico Carmina,et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. , 2012, Fertility and sterility.
[253] D. Cramer,et al. Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[254] Valerie Beral,et al. ORAL CONTRACEPTIVE USE AND MALIGNANCIES OF THE GENITAL TRACT Results from The Royal College of General Practitioners' Oral Contraception Study , 1988, The Lancet.
[255] J. Kotsopoulos,et al. Anthropometric Measures and Risk of Epithelial Ovarian Cancer: Results From the Nurses' Health Study , 2010, Obesity.
[256] N. Day,et al. The epidemiology of ovarian cancer in Greece: a case-control study. , 1984, European journal of cancer & clinical oncology.
[257] A. Whittemore,et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.
[258] S. E. Dietert,et al. Noncontraceptive estrogen use and the occurrence of ovarian cancer. , 1982, Journal of the National Cancer Institute.
[259] R. Ness,et al. Cigarette Smoking and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer , 2002, Epidemiology.
[260] L. Bernstein,et al. Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort , 2010, Cancer Causes & Control.
[261] A. Chetrit,et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. , 1999, Fertility and sterility.
[262] L. Arab. Epidemiologic Evidence on Coffee and Cancer , 2010, Nutrition and cancer.
[263] C. Wahlberg. Tubal ligation, hysterectomy, and risk of ovarian cancer. , 1994, JAMA.
[264] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[265] J. Shelton,et al. Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. , 1983, Journal of the American Medical Association (JAMA).
[266] S. Franceschi,et al. Oral Contraceptives and Cancer , 2001, Drug safety.
[267] N. Weiss,et al. Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer? , 1986, American journal of epidemiology.
[268] H. Xing,et al. Aspirin inhibits growth of ovarian cancer by upregulating caspase-3 and downregulating bcl-2 , 2016, Oncology letters.
[269] A. Whittemore,et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 , 2009, Nature Genetics.
[270] N. Weiss,et al. Recreational physical activity and risk of epithelial ovarian cancer , 2010, Cancer Causes & Control.
[271] Age at menarche and age at natural menopause in East Asian women: a genome-wide association study , 2016, AGE.
[272] E. Greiser,et al. Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. , 2007, Human reproduction update.
[273] H. Adami,et al. Parity, age at first childbirth, and risk of ovarian cancer , 1994, The Lancet.
[274] W. Willett,et al. Prospective study of recreational physical activity and ovarian cancer. , 2001, Journal of the National Cancer Institute.
[275] J. Olsen,et al. Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors , 2005, Cancer Epidemiology Biomarkers & Prevention.
[276] H. Adami,et al. Prospective study of physical activity in different periods of life and the risk of ovarian cancer , 2006, International journal of cancer.
[277] A. McTiernan,et al. Mechanisms linking physical activity with cancer , 2008, Nature Reviews Cancer.
[278] B. Rosner,et al. Talc Use, Variants of the GSTM1, GSTT1, and NAT2 Genes, and Risk of Epithelial Ovarian Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[279] S. Self,et al. Ovarian tumors in a cohort of infertile women. , 1994, The New England journal of medicine.
[280] C. la Vecchia,et al. Pelvic inflammatory disease and risk of ovarian cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[281] C. la Vecchia,et al. Risk factors for epithelial ovarian cancer in women under age 45. , 1993, European journal of cancer.
[282] J. Olsen,et al. Low-dose aspirin use and the risk of ovarian cancer in Denmark. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[283] M. Piver,et al. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. , 1999, Gynecologic oncology.
[284] J. Kendrick,et al. Cigarette smoking and the risk of epithelial ovarian cancer. , 1987, American journal of epidemiology.
[285] D. Seminara,et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[286] Reproductive factors, adiposity, breastfeeding and their associations with ovarian cancer in an Asian cohort , 2015, Cancer Causes & Control.
[287] I. Gram,et al. Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition , 2011, Cancer Causes & Control.
[288] I. Shih,et al. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. , 2004, The American journal of pathology.
[289] I. Gram,et al. An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study , 2015, British Journal of Cancer.
[290] S. Gapstur,et al. Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective US cohort , 2015, Cancer Causes and Control.
[291] D. Easton,et al. A systematic review and meta‐analysis of family history and risk of ovarian cancer , 1998, British journal of obstetrics and gynaecology.
[292] E. Hovig,et al. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study , 2004, British Journal of Cancer.
[293] D. Albanes,et al. Physical activity and risk of ovarian cancer: a prospective cohort study in the United States. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[294] C. la Vecchia,et al. Risk factors for different histological types of ovarian cancer , 2003, International Journal of Gynecologic Cancer.
[295] R. Goldbohm,et al. Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies , 2006, British Journal of Cancer.
[296] A. Trentham-Dietz,et al. Alcohol consumption and ovarian cancer risk in a population‐based case–control study , 2006, International journal of cancer.
[297] V. Beral,et al. Reproductive factors and risk of ovarian cancer: A prospective study , 1988, International journal of cancer.
[298] S. Hankinson,et al. A prospective study of leisure‐time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status , 2016, International journal of cancer.
[299] Laetitia Huiart,et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. , 2011, JAMA.
[300] A. Green,et al. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer , 2008, International journal of cancer.
[301] G. Colditz,et al. Mathematical Models of Ovarian Cancer Incidence , 2005, Epidemiology.
[302] P. Hartge,et al. Risk Prediction for Breast, Endometrial, and Ovarian Cancer in White Women Aged 50 y or Older: Derivation and Validation from Population-Based Cohort Studies , 2013, PLoS medicine.
[303] Jeong-Won Lee,et al. Histologic distribution of borderline ovarian tumors worldwide: a systematic review , 2013, Journal of gynecologic oncology.
[304] S. Jick,et al. Use of metformin and the risk of ovarian cancer: a case-control analysis. , 2011, Gynecologic oncology.
[305] Hui Xu,et al. Vitamin D receptor rs2228570 polymorphism and susceptibly to ovarian cancer: a meta-analysis , 2014, Tumor Biology.
[306] R. Langer,et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. , 2003, JAMA.
[307] R. Goldbohm,et al. Reproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study , 2010, American journal of epidemiology.
[308] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[309] A. Venn,et al. Breast and ovarian cancer incidence after infertility and in vitro fertilisation , 1995, The Lancet.
[310] F. Clavel-Chapelon,et al. Reproductive and hormone‐related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort , 2015, International journal of cancer.
[311] D. Whiteman,et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. , 2007, European journal of cancer.
[312] A. Whittemore,et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 , 2013, Nature Communications.
[313] H. Risch. Estrogen replacement therapy and risk of epithelial ovarian cancer. , 1996, Gynecologic oncology.
[314] K. Oktay,et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[315] Menopausal hormone replacement therapy and risk of ovarian cancer , 2002, JAMA.
[316] N. Weiss,et al. Menopausal Hormone Therapy and Risk of Epithelial Ovarian Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[317] G. Colditz,et al. A prospective study of postmenopausal hormone use and ovarian cancer risk , 2006, British Journal of Cancer.
[318] A. Whittemore,et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes , 2016, Human Genetics.
[319] P. Newcomb,et al. Cigarette smoking in relation to risk of large bowel cancer in women. , 1995, Cancer research.
[320] J. Seidman,et al. Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors. , 2008, Archives of pathology & laboratory medicine.
[321] C. la Vecchia,et al. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. , 1992, American journal of epidemiology.
[322] M. Widschwendter,et al. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. , 2011, Human reproduction update.
[323] C. la Vecchia,et al. Family history of cancer and risk of ovarian cancer. , 2003, European journal of cancer.
[324] A. Jakubowska,et al. Hereditary ovarian cancer in Poland. , 2004, International journal of cancer.
[325] Peter Kraft,et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. , 2016, Cancer discovery.
[326] L. Brinton,et al. Body mass index and risk of ovarian cancer , 2009, Cancer.
[327] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[328] Ie-Ming Shih,et al. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.
[329] A. Whittemore,et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. , 2015, Human molecular genetics.
[330] L. Yoder. The epidemiology of ovarian cancer: a review. , 1990, Oncology nursing forum.
[331] M. McCullough,et al. Leisure-Time Spent Sitting and Site-Specific Cancer Incidence in a Large U.S. Cohort , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[332] J. Krischer,et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases , 2005, Cancer.
[333] Heiner Boeing,et al. Dietary Determinants of Epithelial Ovarian Cancer: A Review of the Epidemiologic Literature , 2004, Nutrition and cancer.
[334] H. Risch,et al. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. , 1996, American journal of epidemiology.
[335] M. Vessey,et al. Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004 , 2006, British Journal of Cancer.
[336] N. de Klerk,et al. Does Exposure to Asbestos Cause Ovarian Cancer? A Systematic Literature Review and Meta-analysis , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[337] H. Chung,et al. Wine drinking and epithelial ovarian cancer risk: a meta-analysis. , 2010, Journal of gynecologic oncology.
[338] M. Gwinn,et al. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. , 1990, Journal of clinical epidemiology.
[339] P. Dickman,et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. , 2002, American journal of epidemiology.
[340] L. Holmberg,et al. Alcoholism and cancer risk: a population-based cohort study , 1992, Cancer Causes & Control.
[341] E. Wynder,et al. Epidemiology of cancer of the ovary , 1969, Cancer.
[342] C. la Vecchia,et al. Menstrual factors and the risk of epithelial ovarian cancer. , 1989, Journal of clinical epidemiology.
[343] A. Whittemore,et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.
[344] A. Whittemore,et al. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. , 1988, American journal of epidemiology.
[345] Richard J. K. Taylor,et al. The impact of changes in hormone therapy on breast cancer incidence in the US population , 2009, Cancer Causes & Control.
[346] G. Reeves,et al. Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type , 2015, International journal of cancer.
[347] S. Larsson,et al. Coffee Consumption Is Not Associated with Ovarian Cancer Incidence , 2005, Cancer Epidemiology Biomarkers & Prevention.
[348] A. Lilienfeld,et al. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. , 1974, American journal of epidemiology.
[349] Orli G. Bahcall,et al. iCOGS collection provides a collaborative model , 2013, Nature Genetics.
[350] L. Titus,et al. The Association Between Talc Use and Ovarian Cancer , 2016, Epidemiology.
[351] P. Hartge,et al. Ovarian cancer risk factors by histologic subtypes in the NIH‐AARP diet and health study , 2012, International journal of cancer.
[352] S. Hankinson,et al. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. , 2014, Fertility and sterility.
[353] R. Goldbohm,et al. Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies , 2008, Cancer Epidemiology Biomarkers & Prevention.
[354] D. Aoki,et al. Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning. , 2016, Oncology letters.
[355] L. Mcgowan. Epidemiology of ovarian cancer. , 1989, Oncology.
[356] Yu-qin Pan,et al. Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk , 2014, Tumor Biology.
[357] E. Weiderpass,et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. , 2002, Journal of the National Cancer Institute.
[358] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[359] A. Whittemore,et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.
[360] W. Willett,et al. Recreational physical activity and ovarian cancer in a population‐based case‐control study , 2002, International journal of cancer.